BiotechMashup

(King's College London) An international consortium of scientists, led by H. Lundbeck A/S and King's College London, has launched one of the largest ever research academic-industry collaboration projects to find new methods for the development of drugs for schizophrenia and depression.

(King's College London) In the first study to systematically investigate genome-wide epigenetic differences in a large number of psychosis discordant twin-pairs, research at the Institute of Psychiatry at King's College London provides further evidence that epigenetic processes play an important role in neuropsychiatric disease. Published in Human Molecular Genetics, the findings may offer potential new avenues for treatment.

(King's College London) Researchers at King's College London's Department of Twin Research have discovered, as part of a large international consortium, 30 new genes that control the age of sexual maturation in women, the Journal Nature Genetics publishes today.

(King's College London) Researchers at King's College London, in collaboration with the Wellcome Trust Sanger Institute, have identified a group of "aging" genes that are switched on and off by natural mechanisms called epigenetic factors, influencing the rate of healthy aging and potential longevity.

(BGI Shenzhen) BGI, the world's largest genomic organization, and Johns Hopkins University today signed a collaborative research agreement for the synthetic yeast project, an ambitious synthetic biology project which seeks to re-design and synthesize the yeast genome.

(King's College London) King's College London, in collaboration with Radboud University Nijmegen Medical Centre in The Netherlands, has discovered a new gene associated with Hypospadias, the congenital malformation of the male genitalia. The research was published today in Nature Genetics.

(King's College London) King's College London has signed a unique agreement with the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, the State of Sao Paulo Research Foundation, Brazil. With this agreement King's has become FAPESP's first and only university partner in the UK.

(BGI Shenzhen) BGI, the world's largest genomic organization, today announced its participation and pivotal role in demonstrating the superior performance of RNA-Seq in predicting patient outcomes as part of the Sequencing Quality Control project launched by the US Food and Drug Administration.

(King's College London) Researchers have revealed the molecular pathway that is affected during the onset of schizophrenia and successfully alleviated symptoms of the illness in mice, using a cancer drug currently in advanced clinical trials.The research, published online in the journal Brain, is from a group led by Professor Peter Giese at King's College London, and offers new avenues for drug discovery.